X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs LUPIN - Comparison Results

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES LUPIN ALKEM LABORATORIES/
LUPIN
 
P/E (TTM) x - 40.6 - View Chart
P/BV x 6.1 2.5 242.6% View Chart
Dividend Yield % 0.7 0.7 107.6%  

Financials

 ALKEM LABORATORIES   LUPIN
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
LUPIN
Mar-18
ALKEM LABORATORIES/
LUPIN
5-Yr Chart
Click to enlarge
High Rs1,5891,465 108.5%   
Low Rs1,232727 169.4%   
Sales per share (Unadj.) Rs417.5349.6 119.4%  
Earnings per share (Unadj.) Rs56.35.6 1,012.9%  
Cash flow per share (Unadj.) Rs64.729.6 218.8%  
Dividends per share (Unadj.) Rs12.705.00 254.0%  
Dividend yield (eoy) %0.90.5 197.4%  
Book value per share (Unadj.) Rs292.9300.3 97.5%  
Shares outstanding (eoy) m119.57452.08 26.4%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x3.43.1 107.8%   
Avg P/E ratio x25.1197.2 12.7%  
P/CF ratio (eoy) x21.837.1 58.8%  
Price / Book Value ratio x4.83.6 131.9%  
Dividend payout %22.690.0 25.1%   
Avg Mkt Cap Rs m168,653495,502 34.0%   
No. of employees `000NA17.0 0.0%   
Total wages/salary Rs m9,17128,647 32.0%   
Avg. sales/employee Rs ThNM9,273.6-  
Avg. wages/employee Rs ThNM1,681.0-  
Avg. net profit/employee Rs ThNM147.4-  
INCOME DATA
Net Sales Rs m49,915158,042 31.6%  
Other income Rs m1,6451,504 109.4%   
Total revenues Rs m51,561159,545 32.3%   
Gross profit Rs m8,48231,475 26.9%  
Depreciation Rs m1,00610,859 9.3%   
Interest Rs m6712,044 32.8%   
Profit before tax Rs m8,45120,076 42.1%   
Minority Interest Rs m-114-71 160.5%   
Prior Period Items Rs m035 0.0%   
Extraordinary Inc (Exp) Rs m0-14,644 0.0%   
Tax Rs m1,6062,885 55.7%   
Profit after tax Rs m6,7312,513 267.9%  
Gross profit margin %17.019.9 85.3%  
Effective tax rate %19.014.4 132.3%   
Net profit margin %13.51.6 848.2%  
BALANCE SHEET DATA
Current assets Rs m27,062122,095 22.2%   
Current liabilities Rs m15,32450,956 30.1%   
Net working cap to sales %23.545.0 52.2%  
Current ratio x1.82.4 73.7%  
Inventory Days Days6785 78.6%  
Debtors Days Days41120 34.4%  
Net fixed assets Rs m12,610129,876 9.7%   
Share capital Rs m239904 26.4%   
"Free" reserves Rs m34,490134,866 25.6%   
Net worth Rs m35,027135,771 25.8%   
Long term debt Rs m1,21264,245 1.9%   
Total assets Rs m54,387263,054 20.7%  
Interest coverage x13.610.8 125.7%   
Debt to equity ratio x00.5 7.3%  
Sales to assets ratio x0.90.6 152.8%   
Return on assets %13.61.7 785.8%  
Return on equity %19.21.9 1,038.4%  
Return on capital %24.93.7 668.2%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,56353,141 12.4%   
Fx outflow Rs m3,01219,335 15.6%   
Net fx Rs m3,55233,807 10.5%   
CASH FLOW
From Operations Rs m7,25917,512 41.4%  
From Investments Rs m1,864-14,073 -13.2%  
From Financial Activity Rs m-9,273-14,921 62.1%  
Net Cashflow Rs m-150-11,482 1.3%  

Share Holding

Indian Promoters % 66.9 46.6 143.6%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 33.1 11.3 292.9%  
FIIs % 0.0 31.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 10.1 -  
Shareholders   68,381 98,259 69.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   NATCO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  ABBOTT INDIA  STRIDES PHARMA SCIENCE  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Turn Volatile; Realty & IT Stocks Gain(12:30 pm)

Share markets in India are presently trading on a flat note. Sectoral indices are trading mixed with stocks in the realty sector and IT sector.

Related Views on News

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

LUPIN LTD Announces Quarterly Results (1QFY19); Net Profit Up 21.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, LUPIN LTD has posted a net profit of Rs 4 bn (up 21.3% YoY). Sales on the other hand came in at Rs 26 bn (up 3.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (4QFY18); Net Profit Down 305.5% (Quarterly Result Update)

Jul 19, 2018 | Updated on Jul 19, 2018

For the quarter ended March 2018, LUPIN LTD has posted a net profit of Rs 8 bn (down 305.5% YoY). Sales on the other hand came in at Rs 40 bn (down 5.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Mar 20, 2019 02:23 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS